Skip to the guide
Tesamorelin
Care field guide
The medicine
Tesamorelin
Tesamorelin copies a hormone signal made in the brain.
It prompts the body to release more of its own growth hormone.
Jump within this page
What the name describes The names on the drug label Put the purpose beside the name
Peptide
A linked chain of the small units used to build proteins.
What the name describes
Tesamorelin is a lab-made peptide.
Its drug labels describe a shot given under the skin.
It acts on the pituitary, a gland that makes hormones.
Hormones are signals; this signal leads to more growth hormone being released.
That is different from giving someone growth hormone itself.
Formulation
The particular form in which a medicine is made.
The names on the drug label
As of September 28, 2026, the approved labels are for tesamorelin (EGRIFTA SV and EGRIFTA WR).
These are different forms of the medicine.
Their labels say they cannot be used in place of each other.
Ask for the full product name when discussing an offer of care.
A useful question
What condition is this meant to treat?
Put the purpose beside the name
A product name alone does not explain why it is being discussed for you.
Have your doctor or other health professional identify the problem, the goal and how to judge progress.
Keep that answer beside the product name in your notes.
Read the term in the approved use Build your visit questions
Brief source notes
What the drug is and how it acts: the tesamorelin (EGRIFTA WR) label.
Continue the primer
Lipodystrophy Browse the word map
This guide explains care options. We run no clinic and sell no medicines.
Starting page Word map Cost Visit questions
Open the text version of this page